美股新聞 標題聯播 · 近 24 小時 348 則 · 31 個來源 · 最新 9/20 04:16
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · BLLN近 30 天 1 則 · 第 1 / 1 頁
- BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin
- /C O R R E C T I O N -- BillionToOne/
- Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
- Why BillionToOne Plummeted 38%, Leading A Medtech Sell-Off
- Can BillionToOne (BLLN) Justify Its Price On Earnings And Reaffirmed 2026 Guidance?
- BillionToOne Inc (BLLN) (Q2 2026) Earnings Call Highlights: Revenue Surges 64% as Oncology and ...
- BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say
- BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
- Does BillionToOne (BLLN) Have Another Major Growth Engine Beyond Prenatal Testing?
- Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test
- BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。